Generic Version

Type: Keyphrase
Name: Generic Version
First reported 6 hours ago - Updated 4 hours ago - 1 reports

Lupin: Earnings upgrades likely after stellar Q1

Lupin's earnings estimates for FY15 are headed for an upgrade, after its strong June quarter numbers. India's third largest pharmaceutical company has benefited hugely from a pick-up in sales in the US. In the quarter, Lupin's revenue grew 37.5 per cent ... [Published Business Standard India - 6 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Court Report -- Part II - July 2014 #2

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .Acorda Therapeutics Inc. v. Actavis Laboratories FL Inc.1:14-cv-00882; filed July 7, 2014 in the District Court of DelawareInfringement of U.S. Patent Nos. ... [Published JD Supra - 6 hours ago]
First reported 12 hours ago - Updated 6 hours ago - 4 reports

Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort Topical Spray 0.25%

You currently are not registered for any FirstWord Pharma services.Register to FirstWord Pharma for free access to 10 articles every 30 days: Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort Topical Spray0.25% You can also: ... [Published FirstWord Pharma - 6 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Gilead Sciences, Inc. Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug

-- Gilead Sciences will allow China and Indian drugmakers to start developing generic formulations of a promising novel HIV/HBV drug, even though the drug’s Phase III tests are still underway. The drug, tenofovir alafenamide (TAF), is a prodrug of the ... [Published BioSpace - 7 hours ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

Fin24.com | SA consumers spend more on medicine

Cape Town - Medicine expenditure among private health care members has increased for the first time since 2011, according to the latest Mediscor Medicine Review results released on Wednesday.Mediscor PBM managing director Christo Rademan said medicine ... [Published Finance 24 - 14 hours ago]
First reported 20 hours ago - Updated 20 hours ago - 1 reports

Court Report -- Part II

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Acorda Therapeutics Inc. v. Actavis Laboratories FL Inc. 1:14-cv-00882; filed July 7, 2014 in the District Court of Delaware Infringement ... [Published Patent Docs - 20 hours ago]
First reported Jul 29 2014 - Updated Jul 30 2014 - 2 reports

Paying for medicine

One year after the introduction of legislation aimed at reducing the price of generic medications in the Republic, the cost of many prescribed drugs remains stubbornly high here compared with elsewhere in the EU. For example, it has emerged that in the ... [Published Irish Times - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Take Two: Just How Good Are Generic Meds Anyway?

A few days ago I wrote a post about generic painkillers and the fact that doctors themselves—who should know better—often don't use them. "If physicians aren't really sold on generics in their own personal lives," I asked, "does this mean they're not ... [Published Kevin Drum Feed | Mother Jones - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 1 reports

Aurobindo, Lupin being sued on generics plans

Multinational drugmakers Pfizer and Forest Laboratories have filed lawsuits against Indian generic company Aurobindo, as it wants to manufacture copycat versions of drugs of which they have patents. Not just Aurobindo, Lupin too is in a similar legal ... [Published Financial Chronicle - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Court Report - July 2014 #3

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .GlaxoSmithKline LLC et al. v. Glenmark Generics Inc. USA1:14-cv-00877; filed July 3, 2014 in the District Court of Delaware• Plaintiffs:  GlaxoSmithKline ... [Published JD Supra - Jul 28 2014]
First reported Jul 26 2014 - Updated Jul 27 2014 - 2 reports

FDA will consider approval of biosimilar drug for first time | The Rundown

Americans are a small step closer to accessing less-expensive specialty drugs known as biologics.The Food and Drug Administration for the first time accepted an application for the approval of a copycat “generic” version of the brand name drug Neupogen, ... [Published DailyMe.Com - Jul 27 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 2 reports

Smart people buy generic brands

These products are the same in all but their names. So why do 26% of Americans buy the one that costs more? br /> Sudafed or Wal-Phed: Which would you choose? Nine times out of 10, pharmacists and doctors will buy the generic version of aspirin, ... [Published AdBanks.net - Jul 25 2014]

Quotes

...Ranjit Kapadia of Centrum Broking says, "Generics players have done well in the US, as there has been a delay in the launch of first-to-file products. Revenues in FY15 are expected to grow above 25 per cent and operating margins should sustain at 30 per cent levels." The stock is currently trading at 22 times its estimated FY16 earnings and analysts believe an upgrade is likely after the current quarter
Infringement of U S Patent Nos. 6,028,071 ( "Purified Compositions of 10-propargyl-10-deazaaminopterin and Methods of Using Same in the Treatment of Tumors" issued February 22, 2000), 7,622,470 ("Treatment of T-cell Lymphoma Using 10-porpargyl-10-deazaaminopterin," issued November 24, 2009), and 8,200,078...
Toronto Stock Exchange Symbol: DND "Our second quarter results show strong increases in revenue, earnings and cash, as our product portfolio continues to perform very well overall" said Shawn O'Brien TotalTotal revenue for Q2 2014 was $8.7 million Re and Development expense for Q2 2014 was $0.3 million
Perrigo's Chairman, President and CEO Joseph C Papa stated, "This filing highlights our continued investment in new products and dedication to bringing topicals to market. Perrigo is committed to making quality healthcare more affordable for consumers around the globe."

More Content

All (715) | News (569) | Reports (0) | Blogs (139) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Hospira's (HSP) CEO Michael Ball on Q2 2014 Res... [Published Seeking Alpha - 5 hours ago]
Lupin: Earnings upgrades likely after stellar Q1 [Published Business Standard India - 6 hours ago]
Using 505(b)(2) to Solve the Financial Shortfal... [Published Applied Clinical Trials - 6 hours ago]
Court Report -- Part II - July 2014 #2 [Published JD Supra - 6 hours ago]
Perrigo Confirms First To File Patent Challenge... [Published FirstWord Pharma - 6 hours ago]
Gilead Sciences, Inc. Allows China/Indian Pharm... [Published BioSpace - 7 hours ago]
Cipher reports financial results for Q2 2014 [Published Noodls - 11 hours ago]
Perrigo Confirms First To File Patent Challenge... [Published Individual.com - 12 hours ago]
Perrigo Confirms First To File Patent Challenge... [Published BusinessWeek - 12 hours ago]
Perrigo Confirms First To File Patent Challenge... [Published PR Newswire: Consumer Products & Retail - 12 hours ago]
Fin24.com | SA consumers spend more on medicine [Published Finance 24 - 14 hours ago]
Bristol-Myers Squibb Company v. Teva Pharmaceut... [Published Lexology - 17 hours ago]
Court Report -- Part II [Published Patent Docs - 20 hours ago]
Paying for medicine [Published Irish Times - Jul 30 2014]
Some veterans paying too much for prescriptions [Published WTAE.com - Jul 29 2014]
Veterans overcharged for prescriptions? [Published WTAE.com - Jul 29 2014]
Sun Pharma-Ranbaxy deal in CCI crosshairs [Published Livemint.com - Jul 29 2014]
Ranbaxy’s performance hinges on generic Diovan [Published Livemint.com - Jul 29 2014]
IDT Australia, Mayne Pharma Ink U.S. Pact For G... [Published Health News Daily - Jul 29 2014]
IDT Australia Mayne Pharma Ink U.S. Pact For Ge... [Published BioPortfolio - Jul 29 2014]
Take Two: Just How Good Are Generic Meds Anyway? [Published Kevin Drum Feed | Mother Jones - Jul 29 2014]
Pfizer, ViiV drag Aurobindo to court over patents [Published Times of India - Jul 29 2014]
Call for greater transparency as drug prices in... [Published Irish Times - Jul 29 2014]
2 Your Health: Average Consumer Chooses Name Br... [Published WBAY Green Bay - Jul 28 2014]
Aurobindo, Lupin being sued on generics plans [Published Financial Chronicle - Jul 28 2014]
Sandoz takes step toward first U.S. generic bio... [Published Drug Store News - Jul 28 2014]
Court Report - July 2014 #3 [Published JD Supra - Jul 28 2014]
Questions about Fruits, Generic Buys, Belts, Em... [Published The Simple Dollar - Jul 28 2014]
CHMP Gives Nod to New Drugs in Cancer Care [Published American Journal of Public Health - Jul 28 2014]
Could Motorola Build The Nexus 6? Details Of "S... [Published Know Your Mobile - Jul 28 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Perrigo Confirms First To File Patent Challenge... [Published PR Newswire: Consumer Products & Retail - 12 hours ago]
DUBLIN, July 30, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified ...
Court Report -- Part II [Published Patent Docs - 20 hours ago]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Acorda Therapeutics Inc. v. Actavis Laboratories FL Inc. 1:14-cv-00882; filed July 7, 2014 in the District Court of Delaware Infringement ...
Take Two: Just How Good Are Generic Meds Anyway? [Published Kevin Drum Feed | Mother Jones - Jul 29 2014]
A few days ago I wrote a post about generic painkillers and the fact that doctors themselves—who should know better—often don't use them. "If physicians aren't really sold on generics in their own personal lives," I asked, "does this mean they're not ...
Questions about Fruits, Generic Buys, Belts, Em... [Published The Simple Dollar - Jul 28 2014]
What’s inside? Here are the questions answered in today’s reader mailbag, boiled down to five word summaries. Click on the number to jump straight down to the question. 1. Time for a credit card? 2. Saving fresh fruits 3. Chefs and doctors buy ...
Smart people buy generic brands [Published AdBanks.net - Jul 25 2014]
These products are the same in all but their names. So why do 26% of Americans buy the one that costs more? br /> Sudafed or Wal-Phed: Which would you choose? Nine times out of 10, pharmacists and doctors will buy the generic version of aspirin, ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Mylan Wins Motion to Enjoin GlaxoSmithKline fro... [Published Financial Services - Jul 17 2014]
Milan District Court Confirms the Validity of A... [Published Financial Services - Jun 12 2014]
ACETO Subsidiary Rising Pharmaceuticals Launche... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
CorePharma, LLC Announces the Launch of Dextroa... [Published Financial Services - Jun 04 2014]
ACETO Subsidiary, Rising Pharmaceuticals, Has L... [Published GlobeNewswire: Acquisitions News - May 27 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.